טוען...
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Nivolumab is a programmed death receptor 1 (PD-1) inhibitor. It is part of a group of drugs known as immune checkpoint blockers, which enable potent and durable T-cell responses against several tumors. We report the case of a patient with a metastatic squamous cell carcinoma, who is being treated wi...
שמור ב:
| הוצא לאור ב: | Case Rep Dermatol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
S. Karger AG
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315375/ https://ncbi.nlm.nih.gov/pubmed/32595466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000505478 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|